Soybean variety A1037425
    22.
    发明授权
    Soybean variety A1037425 有权
    大豆品种A1037425

    公开(公告)号:US08907180B2

    公开(公告)日:2014-12-09

    申请号:US13490379

    申请日:2012-06-06

    CPC分类号: C11B1/00 A01H5/10

    摘要: The invention relates to the soybean variety designated A1037425. Provided by the invention are the seeds, plants and derivatives of the soybean variety A1037425. Also provided by the invention are tissue cultures of the soybean variety A1037425 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety A1037425 with itself or another soybean variety and plants produced by such methods.

    摘要翻译: 本发明涉及称为A1037425的大豆品种。 本发明提供的是大豆品种A1037425的种子,植物和衍生物。 本发明还提供了大豆品种A1037425的组织培养物和从其再生的植物。 本发明还提供了通过将大豆品种A1037425与其本身或另一种大豆品种以及通过这些方法生产的植物杂交来生产大豆植物的方法。

    SOYBEAN VARIETY A1037425
    23.
    发明申请
    SOYBEAN VARIETY A1037425 有权
    大豆变种A1037425

    公开(公告)号:US20130333062A1

    公开(公告)日:2013-12-12

    申请号:US13490379

    申请日:2012-06-06

    CPC分类号: C11B1/00 A01H5/10

    摘要: The invention relates to the soybean variety designated A1037425. Provided by the invention are the seeds, plants and derivatives of the soybean variety A1037425. Also provided by the invention are tissue cultures of the soybean variety A1037425 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety A1037425 with itself or another soybean variety and plants produced by such methods.

    摘要翻译: 本发明涉及称为A1037425的大豆品种。 本发明提供的是大豆品种A1037425的种子,植物和衍生物。 本发明还提供了大豆品种A1037425的组织培养物和从其再生的植物。 本发明还提供了通过将大豆品种A1037425与其本身或另一种大豆品种以及通过这些方法生产的植物杂交来生产大豆植物的方法。

    DIBENZO [B,F] [1,4]OXAZAPINE COMPOUNDS
    25.
    发明申请
    DIBENZO [B,F] [1,4]OXAZAPINE COMPOUNDS 审中-公开
    二苯并[B,F] [1,4]氧杂化合物

    公开(公告)号:US20120178738A1

    公开(公告)日:2012-07-12

    申请号:US13323183

    申请日:2011-12-12

    摘要: The present invention relates to 11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazapine compounds of the formula: where the variables are as defined herein, their salts and pharmaceutically acceptable compositions thereof. Methods of preparing these compounds are also described. These compounds may be used in the treatment of disorders such as schizophrenia, treatment resistant schizophrenia, bipolar disorder, psychotic depression, treatment resistant depression, schizophrenia-associated depression, treatment resistant OCD, autism, senile psychosis, psychotic dementia, L-DOPA induced psychosis, psychogenic polydipsia, psychotic symptoms of neurological disorders, sleep disorders.

    摘要翻译: 本发明涉及下式的11-(哌嗪-1-基)二苯并[b,f] [1,4]恶唑氮化合物:其中变量如本文所定义,其盐和药学上可接受的组合物。 还描述了制备这些化合物的方法。 这些化合物可用于治疗精神分裂症,治疗耐药性精神分裂症,双相性精神障碍,精神病抑郁症,治疗耐药性抑郁症,精神分裂症相关抑郁症,治疗耐药性OCD,孤独症,老年性精神病,精神病性痴呆,L-DOPA诱发的精神病 ,心理性多饮,精神病性神经障碍症状,睡眠障碍。

    Annular Sealing Device
    26.
    发明申请
    Annular Sealing Device 审中-公开
    环形密封装置

    公开(公告)号:US20120061922A1

    公开(公告)日:2012-03-15

    申请号:US13227931

    申请日:2011-09-08

    IPC分类号: F16J15/08 B23P17/00

    摘要: An annular seal comprising a metallic ring having a cross section. The cross section includes an axially extending body portion having a radial width and an axial height. A spaced apart pair of sealing arms extend axially from the body portion, wherein each sealing arm includes a radially opposed arcuate sealing surface. The arcuate sealing surface may be convex, for example. The spaced apart pair of sealing arms are spaced apart a radial distance greater than the radial width of the body portion. A sealing system comprises a plurality of interconnected metallic rings wherein the body portion engages the sealing arms of an adjacent metallic ring.

    摘要翻译: 包括具有横截面的金属环的环形密封件。 横截面包括具有径向宽度和轴向高度的轴向延伸的主体部分。 间隔开的一对密封臂从主体部分轴向延伸,其中每个密封臂包括径向相对的弧形密封表面。 例如,弓形密封表面可以是凸形的。 间隔开的一对密封臂间隔开大于身体部分的径向宽度的径向距离。 密封系统包括多个相互连接的金属环,其中主体部分接合相邻金属环的密封臂。

    Direct drive retrofit for rifles
    27.
    发明授权
    Direct drive retrofit for rifles 有权
    直升机改装步枪

    公开(公告)号:US07739939B2

    公开(公告)日:2010-06-22

    申请号:US12218676

    申请日:2008-07-17

    申请人: Jason Adams

    发明人: Jason Adams

    IPC分类号: F41A5/00

    摘要: A direct drive retrofit system for use with an M-16 or AR-15 rifle for conversion from an impingement system comprising: a gas block, the gas block having a barrel bore and a gas plug bore; a gas plug, the gas plug being inserted into the gas plug bore from the muzzle end; a bolt carrier key, the bolt carrier key being configured to mount directly to a bolt carrier; a rod, the rod being manufactured from a single continuous material stock; and a biasing means; wherein, the rod can be uninstalled without removal of a hand guard or the gas block by extracting the gas plug from the gas plug bore from the muzzle end, the actuating means releasing the rod, the rod being freely extracted thereafter by a user in a single piece.

    摘要翻译: 一种与用于从冲击系统转换的M-16或AR-15步枪一起使用的直接驱动改造系统,包括:气块,气块具有筒孔和气塞孔; 气塞,气塞从枪口端插入气塞孔中; 螺栓承载钥匙,所述螺栓承载钥匙被配置为直接安装到螺栓承载件; 杆,杆由单一连续材料原料制造; 和偏置装置; 其中,可以通过从枪口端从气塞孔提取气塞而不用去除手护板或气块来卸载杆,所述致动装置释放杆,所述杆随后由用户以 单件

    DIBENZO[b,f][1,4]OXAZAPINE COMPOUNDS
    29.
    发明申请
    DIBENZO[b,f][1,4]OXAZAPINE COMPOUNDS 有权
    二苯并[b,f] [1,4]氧杂化合物

    公开(公告)号:US20080255088A1

    公开(公告)日:2008-10-16

    申请号:US12047858

    申请日:2008-03-13

    摘要: The present invention relates to 11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazapine compounds of the formula: where the variables are as defined herein, their salts and pharmaceutically acceptable compositions thereof. Methods of preparing these compounds are also described. These compounds may be used in the treatment of disorders such as schizophrenia, treatment resistant schizophrenia, bipolar disorder, psychotic depression, treatment resistant depression, schizophrenia-associated depression, treatment resistant OCD, autism, senile psychosis, psychotic dementia, L-DOPA induced psychosis, psychogenic polydipsia, psychotic symptoms of neurological disorders, sleep disorders.

    摘要翻译: 本发明涉及下式的11-(哌嗪-1-基)二苯并[b,f] [1,4]恶唑氮化合物:其中变量如本文所定义,其盐和药学上可接受的组合物。 还描述了制备这些化合物的方法。 这些化合物可用于治疗精神分裂症,治疗耐药性精神分裂症,双相性精神障碍,精神病抑郁症,治疗耐药性抑郁症,精神分裂症相关抑郁症,治疗耐药性OCD,孤独症,老年性精神病,精神病性痴呆,L-DOPA诱发的精神病 ,心理性多饮,精神病性神经障碍症状,睡眠障碍。